Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study
- PMID: 14745746
- DOI: 10.1002/pon.709
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study
Abstract
This pilot study examines whether hormone therapy for breast cancer affects cognition. Patients participating in a randomised trial of anastrozole, tamoxifen alone or combined (ATAC) (n=94) and a group of women without breast cancer (n=35) completed a battery of neuropsychological measures. Compared with the control group, the patients were impaired on a processing speed task (p=0.032) and on a measure of immediate verbal memory (p=0.026) after controlling for the use of hormone replacement therapy in both groups. Patient group performance was not significantly related to length of treatment or measures of psychological morbidity. The results showed specific impairments in processing speed and verbal memory in women receiving hormonal therapy for the treatment of breast cancer. Verbal memory may be especially sensitive to changes in oestrogen levels, a finding commonly reported in studies of hormone replacement therapy in healthy women. In view of the increased use of hormone therapies in an adjuvant and preventative setting their impact on cognitive functioning should be investigated more thoroughly.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
-
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.Psychooncology. 2009 Aug;18(8):811-21. doi: 10.1002/pon.1453. Psychooncology. 2009. PMID: 19085975
-
The effects of hormone therapy on cognition in breast cancer.J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):405-12. doi: 10.1016/j.jsbmb.2003.07.001. J Steroid Biochem Mol Biol. 2003. PMID: 14623538
-
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.Hum Reprod. 2006 Feb;21(2):545-53. doi: 10.1093/humrep/dei322. Epub 2005 Oct 6. Hum Reprod. 2006. PMID: 16210385 Clinical Trial.
-
Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature.Minerva Ginecol. 2007 Aug;59(4):387-401. Minerva Ginecol. 2007. PMID: 17923830 Review.
-
Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?Eur J Cancer. 2007 Jun;43(9):1342-7. doi: 10.1016/j.ejca.2007.03.023. Epub 2007 May 17. Eur J Cancer. 2007. PMID: 17499988 Review.
Cited by
-
The Estrogen Receptor α-Cistrome Beyond Breast Cancer.Mol Endocrinol. 2016 Oct;30(10):1046-1058. doi: 10.1210/me.2016-1062. Epub 2016 Aug 4. Mol Endocrinol. 2016. PMID: 27489947 Free PMC article. Review.
-
Inhibition of oestrogen biosynthesis induces mild anxiety in C57BL/6J ovariectomized female mice.Neurosci Bull. 2011 Aug;27(4):241-50. doi: 10.1007/s12264-011-1014-8. Neurosci Bull. 2011. PMID: 21788995 Free PMC article.
-
Letrozole for Female Infertility.Front Endocrinol (Lausanne). 2021 Jun 16;12:676133. doi: 10.3389/fendo.2021.676133. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34220713 Free PMC article. Review.
-
Patterns of change in cognitive function with anastrozole therapy.Cancer. 2015 Aug 1;121(15):2627-36. doi: 10.1002/cncr.29393. Epub 2015 Apr 23. Cancer. 2015. PMID: 25906766 Free PMC article.
-
Safety of aromatase inhibitors in the adjuvant setting.Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):75-89. doi: 10.1007/s10549-007-9704-7. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912638 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
